Public Opinion on Prescription Drugs and Their Prices
(By Grace Sparks, Ashley Kirzinger, Alex Montero, Isabelle Valdes, and Liz Hamel for The Kaiser Family Foundation Published: Oct 04,
Read More(By Grace Sparks, Ashley Kirzinger, Alex Montero, Isabelle Valdes, and Liz Hamel for The Kaiser Family Foundation Published: Oct 04,
Read More(By Alex Cottrill, Juliette Cubanski, and Tricia Neuman for The Kaiser Family Foundation Published: Oct 02, 2024) Use of telehealth,
Read MoreIt is that time of the year again for the deluge of Medicare literature to arrive in your mailbox, but
Read More(By Alex Cottrill, Jeannie Fuglesten Biniek, Tricia Neuman, and Juliette Cubanski for The Kaiser Family Foundation Published: Sep 26, 2024)
Read More(By Nancy Ochieng, Juliette Cubanski, Meredith Freed, and Tricia Neuman for The Kaiser Family Foundation Published: Sep 26, 2024) Each
Read More(By Rylee Wilson for Becker’s Hospital Review) Average Medicare Advantage premiums and Medicare Part D premiums will decrease in 2024,
Read More(By Fred Schulte and Holly K. Hacker for KFF Health News) Federal officials resolved more than a decade ago to
Read MoreBy Margie Zable Fisher for Fortune Well on September 26, 2024 For the government to provide Medicare to 67.4 million
Read MoreBy Julie Carter for Medicare Rights on September 26, 2024 KFF recently analyzed Medicare Advantage (MA) data on prior authorization,
Read MoreBy Greg Slabodkin for BioSpace on Septermber 25, 2024 Novo Nordisk’s blockbuster type 2 diabetes medication is a sure bet
Read More